Funding for this research was provided by:
National Institutes of Health (U54 CA221704(5), U54 CA221704(5))
American Cancer Society (MRSG-18-098-01-CPHPS)
U.S. Department of Defense (E01 W81XWH2210368)
Received: 29 December 2022
Accepted: 9 August 2023
First Online: 14 August 2023
: The authors are accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. The study was conducted in accordance with the Declaration of Helsinki (as revised in 2013). The study was approved by institutional/regional/national ethics/committee/ethics board of Fox Chase Cancer Center (<i>IRB No. 18-9015</i>) and individual consent for this retrospective analysis was waived.
: Not applicable.
: The authors declare no competing interests.